V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210002444 | 210005991 | null | 58.2 | Palliative (P) | 2019-05-25 | 2019-05-30 | PACLITAXEL | null | N | PACLITAXEL | 101472295 |
| 210002445 | 210005992 | 1.7 | 70 | Adjuvant (A) | 2021-06-24 | 2021-09-20 | Paclitaxel 7 day | null | N | PACLITAXEL | 100482271 |
| 210002447 | 210005993 | 1.52 | 60.5 | Adjuvant (A) | 2020-11-10 | 2020-11-18 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100523914 |
| 210002449 | 210005995 | 1.52 | 86 | Adjuvant (A) | 2019-09-30 | 2019-09-30 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101699830 |
| 210002455 | 210005999 | 1.62 | 46.55 | Adjuvant (A) | 2019-08-01 | 2019-10-10 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100766845 |
| 210002456 | 210006000 | 1.52 | 68.9 | Adjuvant (A) | null | 2017-04-11 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 101297976 |
| 210002458 | 210006001 | 1.62 | 81 | Adjuvant (A) | 2016-12-07 | 2016-12-22 | Docetaxel | 02 | N | DOCETAXEL | 100000984 |
| 210002459 | 210006002 | 1.67 | 75.6 | Neo-adjuvant (N) | 2017-08-14 | 2019-06-02 | Trastuzumab | 02 | N | TRASTUZUMAB | 100055273 |
| 210002460 | 210006003 | 1.71 | 54.1 | Palliative (P) | 2018-05-26 | 2018-06-10 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100786836 |
| 210002462 | 210006004 | 1.55 | 68.2 | Adjuvant (A) | 2019-06-02 | 2019-06-11 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 100893409 |
| 210002464 | 210006006 | null | 75.9 | null | 2018-09-21 | 2018-09-23 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101255784 |
| 210002465 | 210006007 | null | 83.4 | null | null | 2020-02-09 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 101080966 |
| 210002466 | 210006008 | 1.61 | 81.6 | Curative (C) | 2017-05-21 | 2017-06-05 | Docetaxel | 02 | null | DOCETAXEL | 101413307 |
| 210002467 | 210006009 | 1.58 | 100.8 | Adjuvant (A) | 2017-02-18 | 2017-03-06 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100194392 |
| 210002468 | 210006010 | null | 43.6 | Adjuvant (A) | 2017-12-10 | 2017-12-26 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101648553 |
| 210002470 | 210006011 | 1.6 | 77.3 | Adjuvant (A) | null | 2020-11-21 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | Y | PACLITAXEL | 100373577 |
| 210002474 | 210006014 | 1.57 | 74.2 | Palliative (P) | 2022-02-11 | 2022-03-05 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101559598 |
| 210002475 | 210006015 | 1.68 | 92 | null | null | 2021-01-16 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101013686 |
| 210002476 | 210006016 | 1.59 | 55.4 | Adjuvant (A) | null | 2018-05-07 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100050182 |
| 210002483 | 210006020 | null | null | null | 2018-04-26 | 2018-05-03 | Docetaxel | null | null | DOCETAXEL | 100752618 |
| 210002487 | 210006022 | null | 55.7 | Adjuvant (A) | 2018-06-21 | 2018-07-04 | Docetaxel | 01 | N | DOCETAXEL | 101683954 |
| 210002490 | 210006024 | 1.66 | 111.2 | null | 2018-11-08 | 2018-11-29 | Trastuzumab | N | null | TRASTUZUMAB | 100877914 |
| 210002491 | 210006025 | 1.61 | 81.1 | Neo-adjuvant (N) | 2016-10-24 | 2016-10-24 | Paclitaxel 80mg/m2 day 1 8 15 | null | N | PACLITAXEL | 100515589 |
| 210002492 | 210006026 | 1.68 | 57.7 | Adjuvant (A) | 2019-11-23 | 2019-11-30 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 100166502 |
| 210002494 | 210006027 | 1.63 | 59 | Neo-adjuvant (N) | 2020-07-28 | 2020-08-15 | Docetaxel 100mg/m2 (21 day) | null | N | DOCETAXEL | 100780134 |
| 210002495 | 210006028 | null | 70.7 | null | 2017-08-17 | 2017-08-17 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100750600 |
| 210002496 | 210006029 | 1.67 | 59.2 | null | 2016-06-05 | 2016-06-27 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101241030 |
| 210002500 | 210006031 | null | 66.4 | null | null | 2016-05-01 | Docetaxel 100mg/m2 (21 day) | null | null | DOCETAXEL | 101257877 |
| 210002502 | 210006033 | 1.71 | 114 | Neo-adjuvant (N) | 2018-08-01 | 2018-08-09 | Docetaxel | 02 | N | DOCETAXEL | 100699638 |
| 210002504 | 210006035 | 1.56 | 82.4 | Neo-adjuvant (N) | 2016-07-14 | 2016-07-28 | Trastuzumab | 02 | N | TRASTUZUMAB | 100581163 |
| 210002505 | 210006036 | 1.65 | 87 | Adjuvant (A) | 2018-10-14 | 2018-10-29 | EC | 01 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101265246 |
| 210002506 | 210006037 | 1.67 | 92.4 | Adjuvant (A) | 2020-01-19 | 2020-01-19 | Docetaxel | 02 | N | DOCETAXEL | 101345386 |
| 210002508 | 210006039 | 1.64 | 87 | Adjuvant (A) | 2018-05-04 | 2018-05-12 | PACLITAXEL | null | N | PACLITAXEL | 101078679 |
| 210002510 | 210006041 | 1.88 | 106.6 | null | 2018-04-30 | 2018-05-21 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 101049232 |
| 210002511 | 210006042 | 1.64 | 57 | Adjuvant (A) | 2018-03-03 | 2018-03-11 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101843454 |
| 210002513 | 210006043 | 1.59 | 106.4 | null | null | 2018-08-17 | PACLITAXEL | null | null | PACLITAXEL | 101270981 |
| 210002514 | 210006044 | 1.64 | null | Adjuvant (A) | 2016-12-30 | 2017-10-10 | Paclitaxel 80mg/m2 day 1 8 15 | null | N | PACLITAXEL | 100862573 |
| 210002515 | 210006045 | 1.6 | 93 | Adjuvant (A) | null | 2019-06-23 | Paclitaxel 7 day | null | N | PACLITAXEL | 100600748 |
| 210002519 | 210006046 | 1.54 | 86.9 | Adjuvant (A) | null | 2019-12-26 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100651174 |
| 210002520 | 210006047 | null | 55.8 | null | 2017-04-09 | 2017-04-17 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100491202 |
| 210002521 | 210006048 | 1.64 | 86.9 | Adjuvant (A) | 2018-09-20 | 2018-09-27 | Docetaxel | 02 | N | DOCETAXEL | 101405419 |
| 210002522 | 210006049 | 1.72 | 70.2 | Curative (C) | 2018-03-19 | 2018-03-19 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 101105884 |
| 210002524 | 210006051 | 1.44 | 69.3 | Adjuvant (A) | 2018-06-13 | 2018-06-28 | Docetaxel | 02 | N | DOCETAXEL | 101644209 |
| 210002527 | 210006053 | 1.53 | 67.4 | Neo-adjuvant (N) | 2016-12-18 | 2016-12-18 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100653585 |
| 210002528 | 210006054 | 1.54 | 96 | Adjuvant (A) | 2018-11-21 | 2018-12-05 | Docetaxel | N | N | DOCETAXEL | 101433878 |
| 210002530 | 210006055 | 1.67 | 71.4 | Adjuvant (A) | 2019-12-09 | 2019-12-09 | Docetaxel | 02 | N | DOCETAXEL | 100979294 |
| 210002531 | 210006056 | null | 66.4 | null | 2017-07-18 | 2017-10-01 | Paclitaxel 80mg/m2 day 1 8 15 | null | null | PACLITAXEL | 101501732 |
| 210002532 | 210006057 | 1.5 | 72.2 | Adjuvant (A) | null | 2018-02-14 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101630980 |
| 210002533 | 210006058 | 1.62 | 115 | Neo-adjuvant (N) | null | 2017-04-18 | Docetaxel | 02 | N | DOCETAXEL | 100734174 |
| 210002534 | 210006059 | null | 82.5 | null | 2016-03-07 | 2016-04-30 | Trastuzumab | 02 | null | TRASTUZUMAB | 101568294 |